John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$254M |
| 2 |
Bank of America
BAC
|
+$228M |
| 3 |
KLA
KLAC
|
+$205M |
| 4 |
TSMC
TSM
|
+$191M |
| 5 |
CVS Health
CVS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Goldman Sachs
GS
|
+$237M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
PayPal
PYPL
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.66% |
| 3 | Financials | 12.92% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Pulmonx
LUNG
$98.4M
| $227K | ﹤0.01% |
27,441
-37,048
| -57% | -$268K |
|
2727
Amneal Pharmaceuticals
AMRX
$6.2B
| $227K | ﹤0.01% |
27,245
-30,543
| -53% | -$239K |
|
2728
GEN Restaurant Group
GENK
$10.5M
| $226K | ﹤0.01% |
26,819
-9,050
| -25% | -$76.8K |
|
2729
Arhaus
ARHS
$1.31B
| $225K | ﹤0.01% |
18,294
-110
| -0.6% | -$1.49K |
|
2730
First Trust Dow Jones Select MicroCap Index Fund
FDM
$270M
| $224K | ﹤0.01% |
+3,500
| New | +$219K |
|
2731
ACI Worldwide
ACIW
$5.3B
| $224K | ﹤0.01% |
+4,401
| New | +$201K |
|
2732
Greenland Technologies Holding
GTEC
$25M
| $224K | ﹤0.01% |
+90,592
| New | +$174K |
|
2733
EVI Industries
EVI
$189M
| $224K | ﹤0.01% |
11,566
-248
| -2% | -$4.45K |
|
2734
Smith Douglas Homes
SDHC
$105M
| $223K | ﹤0.01% |
+5,908
| New | +$189K |
|
2735
Applied Finance Valuation Large Cap ETF
VSLU
$565M
| $223K | ﹤0.01% |
+6,200
| New | +$215K |
|
2736
CarParts.com
PRTS
$49.6M
| $221K | ﹤0.01% |
24,419
+19,116
| +360% | +$181K |
|
|
ITI
2737
DELISTED
Iteris, Inc.
ITI
| $221K | ﹤0.01% |
30,910
+8,026
| +35% | +$47.9K |
|
|
ZBIO
2738
Zenas BioPharma
ZBIO
$2.07B
| $220K | ﹤0.01% |
+13,000
| New | +$234K |
|
2739
Badger Meter
BMI
$3.87B
| $219K | ﹤0.01% |
1,001
-30,754
| -97% | -$6.16M |
|
|
RERE
2740
ATRenew
RERE
$913M
| $218K | ﹤0.01% |
78,516
+5,400
| +7% | +$13.1K |
|
2741
AC Immune
ACIU
$283M
| $217K | ﹤0.01% |
57,321
-42,022
| -42% | -$147K |
|
2742
Blackbaud
BLKB
$2.19B
| $217K | ﹤0.01% |
2,558
-200
| -7% | -$15.9K |
|
2743
Limbach Holdings
LMB
$501M
| $216K | ﹤0.01% |
2,852
-2,984
| -51% | -$190K |
|
2744
CorMedix
CRMD
$641M
| $213K | ﹤0.01% |
26,300
-130,436
| -83% | -$706K |
|
2745
AdvanSix
ASIX
$452M
| $212K | ﹤0.01% |
+6,962
| New | +$190K |
|
2746
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.35B
| $211K | ﹤0.01% |
+2,200
| New | +$202K |
|
|
ACB
2747
Aurora Cannabis
ACB
$254M
| $210K | ﹤0.01% |
35,776
-40,798
| -53% | -$242K |
|
|
BGFV
2748
DELISTED
Big 5 Sporting Goods
BGFV
| $209K | ﹤0.01% |
100,218
+49,561
| +98% | +$106K |
|
2749
Cartesian Therapeutics
RNAC
$308M
| $208K | ﹤0.01% |
+12,911
| New | +$202K |
|
2750
ALPS Dynamic US Dividend Advantage ETF
RFDA
$83M
| $204K | ﹤0.01% |
+3,700
| New | +$198K |
|
Similar funds
John Overdeck's Q3 2024 Portfolio in Review
As of Q3 2024, John Overdeck held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
John Overdeck withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Bank of America worth $226M.
- John Overdeck's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
- John Overdeck added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
- John Overdeck's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
- John Overdeck fully exited Intel in Q3 2024, selling an estimated $161M.
- John Overdeck's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
- John Overdeck opened 444 new positions and closed 348 in Q3 2024.
- John Overdeck's portfolio value rose 3.9% quarter-over-quarter to $45.6B.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.